Active Awards Portfolio Dashboard
It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.

Filter Awards
Disease![]() |
Cell Type | Therapeutic or Technology | Institution | Stage | Project Objective | Details |
---|---|---|---|---|---|---|
Muscle Injury | Adult Stem Cell | Personalized cell therapy | UCSF |
![]() |
Development Candidate, Proof of Concept | |
Muscular Dystrophy | Embryonic Stem Cell | Protein/peptide therapy | Juvena Therapeutics Inc |
![]() |
Pre-IND/IDE or Equivalent | |
Neurological Disorders | iPS Cell | Gene Therapy, cell free | Navega Therapeutics |
![]() |
Development Candidate, Proof of Concept | |
Neurological Disorders, Sanfilippo Syndrome/MPS III |
iPS Cell | Gene-modified, personalized cell therapy | UC Irvine |
![]() |
Development Candidate, Proof of Concept | |
Other | Adult Stem Cell | Protein/peptide therapy | Intact Therapeutics, Inc. |
![]() |
Development Candidate, Proof of Concept | |
Ovarian Cancer | Adult Stem Cell | Gene-modified, personalized cell therapy | COH |
![]() |
Development Candidate, Proof of Concept | |
Ovarian Cancer | iPS Cell | Gene-modified, donor cell therapy | UCSD |
![]() |
Development Candidate, Proof of Concept | |
Ovarian Cancer | Adult Stem Cell | Gene-modified, donor cell therapy | COH |
![]() |
Pre-IND/IDE or Equivalent | |
Pancreatic Cancer | Cancer Stem Cell | Small molecule therapy | UCSD |
![]() |
Development Candidate, Proof of Concept | |
Parkinson's Disease | Vital Research Opportunity | Gene Therapy, cell free | Brain Neurotherapy Bio |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Parkinson's Disease | Adult Stem Cell | Gene-modified, donor cell therapy | UCSF |
![]() |
IND | |
Pulmonary Hypertension, Vascular Disease |
Adult Stem Cell | Donor cell therapy | Cedars-Sinai |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Retinitis Pigmentosa | Therapeutic Approach | jCyte |
![]() |
Clinical Trial, Phase 2 | ||
Retinitis Pigmentosa | Adult Stem Cell | Donor cell therapy | Cedars-Sinai |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Retinitis Pigmentosa | Other | Donor cell therapy | jCyte |
![]() |
Clinical Trial, Phase 2 | |
Retinitis Pigmentosa | Embryonic Stem Cell | Donor cell therapy | UC Irvine |
![]() |
Pre-IND/IDE or Equivalent | |
Retinitis Pigmentosa | Somatic Cell | Gene Therapy, cell free | Ray Therapeutics, INC |
![]() |
Pre-IND/IDE or Equivalent | |
Sarcoma | Adult Stem Cell | Gene-modified, personalized cell therapy | Stanford |
![]() |
Development Candidate, Proof of Concept | |
Sarcoma | Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Severe Combined Immunodeficiency, Artemis deficient (ART-SCID) | Adult Stem Cell | Gene-modified, personalized cell therapy | UCSF |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Severe Combined Immunodeficiency, X-linked (X-SCID) | Adult Stem Cell | Antibody | Jasper Therapeutics, Inc. |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Sickle Cell Disease | Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Sickle Cell Disease | Adult Stem Cell | Gene-modified, personalized cell therapy | Boston Children's Hospital |
![]() |
Clinical Trial, Phase 2 | |
Sickle Cell Disease | Adult Stem Cell | Donor cell therapy | COH |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Sickle Cell Disease | Adult Stem Cell | Gene-modified, personalized cell therapy | UCSF |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Sickle Cell Disease | Adult Stem Cell | Gene-modified, personalized cell therapy | UCSF |
![]() |
IND | |
Sickle Cell Disease | Adult Stem Cell | Donor cell therapy | ExCellThera Inc. |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Solid Tumors | BioEclipse Therapeutics INC. |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |||
Spina Bifida | Adult Stem Cell | Donor cell therapy | UC Davis |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Spinal Cord Injury | Embryonic Stem Cell | Donor cell therapy | UCSD |
![]() |
Pre-IND/IDE or Equivalent | |
Spinal Cord Injury | Embryonic Stem Cell | Gene-modified, donor cell therapy | UCSD |
![]() |
Development Candidate, Research Insights | |
Spinal Cord Injury | Adult Stem Cell | Donor cell therapy | UC Irvine |
![]() |
Pre-IND/IDE or Equivalent | |
Spinal Cord Injury | iPS Cell | Donor cell therapy | Stanford |
![]() |
Development Candidate, Proof of Concept | |
Stroke | Embryonic Stem Cell | Donor cell therapy | Stanford |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Stroke | iPS Cell | Donor cell therapy | UCLA |
![]() |
Pre-IND/IDE or Equivalent | |
Traumatic Brain Injury | Embryonic Stem Cell | Donor cell therapy | UC Irvine |
![]() |
Pre-IND/IDE or Equivalent | |
Traumatic Brain Injury | Embryonic Stem Cell | Exosomes based therapy | UC Irvine |
![]() |
Development Candidate, Proof of Concept, Research Insights | |
Traumatic Brain Injury | iPS Cell | Donor cell therapy | UC Irvine |
![]() |
Development Candidate, Research Insights | |
Type 1 diabetes | iPS Cell | Biologic | UCLA |
![]() |
Development Candidate, Proof of Concept | |
Type 1 diabetes | Embryonic Stem Cell | Gene-modified, donor cell therapy | Salk |
![]() |
Development Candidate, Proof of Concept | |
Type 1 diabetes | Embryonic Stem Cell | Gene-modified, donor cell therapy | Lundquist Institute |
![]() |
Development Candidate, Proof of Concept | |
Type 1 diabetes | Adult Stem Cell | Donor cell therapy | UCSF |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Type 1 diabetes | Embryonic Stem Cell | Donor cell therapy | ViaCyte |
![]() |
Clinical Trial, Phase 1 or Phase 1/2 | |
Vascular Disease | Adult Stem Cell | Biologic | UCSD |
![]() |
Pre-IND/IDE or Equivalent | |
Wounds, ulcers | Small molecule therapy | UCLA |
![]() |
IND |
Pages
- « first
- ‹ previous
- 1
- 2
- 3